reinforce soft tissue
Devicereinforce soft tissue
NCT Number: NCT01602081
The LIFT+Biodesign® study is a post-market observational study to evaluate the rate of fistula closure in patients with persistent trans-sphincteric anal fistula who receive the Biodesign® Tissue graft as part of their LIFT procedure.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
University of California Irvine, Orange, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
reinforce soft tissue
Time frame: 6 months
Time frame: 12 months
Cook Group Incorporated
Industry
Ligation of the Intersphincteric Fistula Tract With Tissue Graft Placement for Treatment of Persistent Trans-sphincteric Anal Fistula
Acronym: LIFT+Graft
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07579715
Anal Fistula, Digestive System Diseases
Islamabad, Pakistan
View Trial DetailsNCT07102134
Anal Fistula, Anal Fistula Surgery
Guangzhou, Guangdong, China
View Trial DetailsNCT06184438
Anal Fistula, Digestive System Diseases
New Taipei City, Taiwan
View Trial DetailsNCT06887166
Anal Fistula, Central Nervous System Diseases
Al Mansurah, Dakahliya, Egypt
View Trial Details